Sputum

Apr 27, 2020

MicroGenDX Receives FDA Emergency Use Authorization for COVID-19 Test to Expand Testing Capacity

Feb 03, 2020

Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis

Dec 02, 2019

CSA Medical, Inc. Announces European Approval for its RejuvenAir® System for COPD Patients with Chronic Bronchitis

Oct 02, 2019

Karius Test® Demonstrates Ability To Detect Pathogens Standard Tests Can Miss In Pneumonia Cases

Sep 04, 2019

Gala Therapeutics Receives CE Mark for its Minimally Invasive RheOx(TM) System for Chronic Bronchitis

Jul 09, 2019

Pulmatrix Activates Sites for Pulmazole Phase 2 Clinical Study

Apr 23, 2019

PrimeStore® MTM opens Sputum-free Molecular Screening for M. tuberculosis Infection

Feb 05, 2019

Akonni Biosystems Awarded Phase II NIH Contract to Advance its Device to Purify DNA from Sputum for Tuberculosis Testing

Sep 18, 2018

RejuvenAir® Metered Cryospray(TM) Shows Promise as Treatment for COPD Patients with Chronic Bronchitis

Mar 01, 2018

CSA Medical Announces the Completion of Treatments in the RejuvenAir Safety and Feasibility Study for patients with Chronic Bronchitis

Sep 11, 2017

CSA Medical Presented Early Clinical Data on the RejuvenAir Metered Cryospray System at the European Respiratory Society (ERS) Conference